Skip to main content

Biotechs get creative in hunt for money

Adam Lenain, a member of Mintz’s San Diego office, counsels technology companies, both public and private, on matters including mergers and acquisitions, licensing and collaborations, and general corporate and securities issues. He was recently featured in an article published by Our City San Diego on the subject of biotechnology companies and their implementation of innovative methods and ideas for acquiring funds.


Our City San Diego